SCOTTSDALE, Ariz.--(BUSINESS WIRE)--VivaMed BioPharma (VivaMed), a clinical-stage pharmaceutical company leveraging Artificial Intelligence (AI) to discover and advance repurposed and improved ...
VivaMed BioPharma (VivaMed), a clinical-stage pharmaceutical company leveraging Artificial Intelligence (AI) to discover and advance repurposed and improved therapeutic assets, today announced a ...
SCOTTSDALE, Ariz., February 19, 2026--(BUSINESS WIRE)--VivaMed BioPharma (VivaMed), a clinical-stage pharmaceutical company leveraging Artificial Intelligence (AI) to discover and advance repurposed ...
The High Potency Active Pharmaceutical Ingredients Market is anticipated to witness steady and sustained expansion, with an estimated compound annual growth rate of approximately 9% over the forecast ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Syngene International has entered a strategic collaboration with VivaMed BioPharma to advance AI-derived repurposed therapeutic programmes. This partnership aims to broaden VivaMed’s validation ...
This year, Italian company Procos marks two important milestones: 80 years since its establishment and 20 years since its acquisition by CBC Group, a Japanese global trading company. “I’m proud of ...
Copyright 2020 FactSet Research Systems Inc. All rights reserved. Source: FactSet Fundamentals Stocks: Real-time U.S. stock quotes reflect trades reported through ...
Syngene: How should one position for it after a disappointing quarter? The company’s investment in biologics and new modalities is promising. While some of these facilities should start contributing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results